The possible causes for intrinsic and acquired resistance have been attributed to the pharmacology of tamoxifen, alterations in the structure and function of the ERα, the interactions with the tumour environment and genetic alterations in the tumour cells [40]. The gene discussed is ESR1; the disease is neoplasm.